Celldex Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2011
Total Assets: $98.0M
Liabilities Breakdown FY2011
Total Liabilities: $29.3M
Asset Breakdown
Total Assets: $98.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $11.9M | 12.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $9.1M | 9.3% |
| Goodwill | $9.0M | 9.1% |
| Intangible Assets | $24.9M | 25.4% |
| Other Assets | $43.1M | 44.0% |
Liabilities Breakdown
Total Liabilities: $29.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $935.0K | 3.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $28.3M | 96.8% |